Clinical trial

Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients…

NCT00016198 · Prologue Research International, Industry · Completed

Key facts

NCT number NCT00016198
Title Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer
Official title A Randomized, Multicenter, Phase II Study Of Bolus/Infusion 5-FU/LV (de Gramont Regimen) Versus Oxaliplatin And Bolus/Infusion 5-FU/LV (de Gramont Regimen) As Third-Line Treatment Of Patients With Metastatic Colorectal Carcinoma
Lead sponsor Prologue Research International, Industry
Status Completed
Phase Phase 2
Study type Interventional
Conditions Colorectal Cancer
Intervention type Drug
Interventions FOLFOX regimen, fluorouracil, leucovorin calcium, oxaliplatin
Start date May 1, 2001
Primary completion Apr 1, 2003
Completion Dec 1, 2010
First posted Jan 7, 2004
Last update posted Jun 26, 2013
Countries United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies